Estatus epiléptico no convulsivo secundario a cefepima a dosis ajustadas en enfermos con insuficiencia renal crónica
Leído
20806
Vecesse ha leído el artículo
478
Total PDF
20328
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 141 | 0 | 141 |
| 2025 5 | 230 | 0 | 230 |
| 2025 4 | 188 | 0 | 188 |
| 2025 3 | 221 | 0 | 221 |
| 2025 2 | 218 | 0 | 218 |
| 2025 1 | 188 | 0 | 188 |
| 2024 12 | 147 | 0 | 147 |
| 2024 11 | 142 | 0 | 142 |
| 2024 10 | 128 | 0 | 128 |
| 2024 9 | 184 | 0 | 184 |
| 2024 8 | 172 | 0 | 172 |
| 2024 7 | 185 | 0 | 185 |
| 2024 6 | 181 | 0 | 181 |
| 2024 5 | 262 | 0 | 262 |
| 2024 4 | 183 | 0 | 183 |
| 2024 3 | 148 | 2 | 150 |
| 2024 2 | 165 | 12 | 177 |
| 2024 1 | 169 | 5 | 174 |
| 2023 12 | 114 | 11 | 125 |
| 2023 11 | 136 | 12 | 148 |
| 2023 10 | 183 | 12 | 195 |
| 2023 9 | 196 | 13 | 209 |
| 2023 8 | 175 | 5 | 180 |
| 2023 7 | 270 | 6 | 276 |
| 2023 6 | 166 | 9 | 175 |
| 2023 5 | 228 | 11 | 239 |
| 2023 4 | 156 | 2 | 158 |
| 2023 3 | 166 | 0 | 166 |
| 2023 2 | 113 | 1 | 114 |
| 2022 1 | 156 | 1 | 157 |
| 2022 12 | 90 | 1 | 91 |
| 2022 11 | 154 | 3 | 157 |
| 2022 10 | 111 | 0 | 111 |
| 2022 9 | 140 | 1 | 141 |
| 2022 8 | 93 | 1 | 94 |
| 2022 7 | 97 | 1 | 98 |
| 2022 6 | 114 | 0 | 114 |
| 2022 5 | 100 | 1 | 101 |
| 2022 4 | 130 | 0 | 130 |
| 2022 3 | 110 | 1 | 111 |
| 2022 2 | 103 | 1 | 104 |
| 2021 1 | 168 | 2 | 170 |
| 2021 12 | 125 | 0 | 125 |
| 2021 11 | 147 | 1 | 148 |
| 2021 10 | 175 | 0 | 175 |
| 2021 9 | 148 | 1 | 149 |
| 2021 8 | 209 | 0 | 209 |
| 2021 7 | 189 | 3 | 192 |
| 2021 6 | 132 | 4 | 136 |
| 2021 5 | 152 | 2 | 154 |
| 2021 4 | 386 | 0 | 386 |
| 2021 3 | 184 | 1 | 185 |
| 2021 2 | 188 | 4 | 192 |
| 2020 1 | 96 | 5 | 101 |
| 2020 12 | 118 | 0 | 118 |
| 2020 11 | 144 | 0 | 144 |
| 2020 10 | 113 | 2 | 115 |
| 2020 9 | 100 | 4 | 104 |
| 2020 8 | 109 | 0 | 109 |
| 2020 7 | 98 | 0 | 98 |
| 2020 6 | 130 | 1 | 131 |
| 2020 5 | 116 | 4 | 120 |
| 2020 4 | 136 | 5 | 141 |
| 2020 3 | 145 | 10 | 155 |
| 2020 2 | 132 | 6 | 138 |
| 2020 1 | 126 | 7 | 133 |
| 2019 12 | 91 | 4 | 95 |
| 2019 11 | 140 | 3 | 143 |
| 2019 10 | 196 | 2 | 198 |
| 2019 9 | 169 | 2 | 171 |
| 2019 8 | 110 | 1 | 111 |
| 2019 7 | 124 | 0 | 124 |
| 2019 6 | 130 | 3 | 133 |
| 2019 5 | 150 | 0 | 150 |
| 2019 4 | 193 | 10 | 203 |
| 2019 3 | 87 | 48 | 135 |
| 2019 2 | 58 | 4 | 62 |
| 2019 1 | 64 | 5 | 69 |
| 2018 12 | 139 | 20 | 159 |
| 2018 11 | 155 | 9 | 164 |
| 2018 10 | 195 | 14 | 209 |
| 2018 9 | 197 | 4 | 201 |
| 2018 8 | 94 | 11 | 105 |
| 2018 7 | 82 | 4 | 86 |
| 2018 6 | 113 | 11 | 124 |
| 2018 5 | 116 | 9 | 125 |
| 2018 4 | 90 | 6 | 96 |
| 2018 3 | 101 | 7 | 108 |
| 2018 2 | 76 | 6 | 82 |
| 2018 1 | 73 | 8 | 81 |
| 2017 12 | 70 | 5 | 75 |
| 2017 11 | 72 | 7 | 79 |
| 2017 10 | 102 | 8 | 110 |
| 2017 9 | 75 | 5 | 80 |
| 2017 8 | 81 | 6 | 87 |
| 2017 7 | 88 | 1 | 89 |
| 2017 6 | 62 | 7 | 69 |
| 2017 5 | 87 | 2 | 89 |
| 2017 4 | 45 | 2 | 47 |
| 2017 3 | 100 | 7 | 107 |
| 2017 2 | 204 | 4 | 208 |
| 2016 1 | 88 | 5 | 93 |
| 2016 12 | 80 | 8 | 88 |
| 2016 11 | 164 | 27 | 191 |
| 2016 10 | 190 | 15 | 205 |
| 2016 9 | 316 | 4 | 320 |
| 2016 8 | 316 | 0 | 316 |
| 2016 7 | 220 | 0 | 220 |
| 2016 6 | 178 | 0 | 178 |
| 2016 5 | 177 | 0 | 177 |
| 2016 4 | 152 | 0 | 152 |
| 2016 3 | 124 | 0 | 124 |
| 2016 2 | 162 | 0 | 162 |
| 2015 1 | 124 | 0 | 124 |
| 2015 12 | 122 | 0 | 122 |
| 2015 11 | 121 | 0 | 121 |
| 2015 10 | 95 | 0 | 95 |
| 2015 9 | 107 | 0 | 107 |
| 2015 8 | 110 | 0 | 110 |
| 2015 7 | 136 | 0 | 136 |
| 2015 6 | 82 | 0 | 82 |
| 2015 5 | 129 | 0 | 129 |
| 2015 4 | 44 | 0 | 44 |
| 2015 2 | 2843 | 0 | 2843 |
Mostrar todo
